デフォルト表紙
市場調査レポート
商品コード
1124254

世界のTNF阻害剤市場:考察と予測 (2028年まで)

Global TNF Inhibitors Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 106 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.53円
世界のTNF阻害剤市場:考察と予測 (2028年まで)
出版日: 2022年09月12日
発行: QYResearch
ページ情報: 英文 106 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、TNF阻害剤 (TNF Inhibitors) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のTNF阻害剤の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Monotherapy
    • Combination Therapy
  • 市場:アプリケーション別
    • 世界のTNF阻害剤の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Skin Disease
    • Ankylosing Spondylitis
    • Gastrointestinal Disease
    • Rheumatoid Arthritis
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のTNF阻害剤の市場展望 (2017-2028)
  • TNF阻害剤の市場成長トレンド:地域別
    • TNF阻害剤 市場規模:地域別: 2017 VS 2021 VS 2028
    • TNF阻害剤の市場規模実績:地域別 (2017-2022)
    • TNF阻害剤の市場規模予測:地域別 (2023-2028)
  • TNF阻害剤 市場動向
    • TNF阻害剤 業界動向
    • TNF阻害剤 市場の促進要因
    • TNF阻害剤 市場の課題
    • TNF阻害剤 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のTNF阻害剤の上位企業:収益別
    • 世界のTNF阻害剤の上位企業:収益別 (2017-2022)
    • 世界のTNF阻害剤の収益シェア:企業別 (2017-2022)
  • 世界のTNF阻害剤の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:TNF阻害剤の収益
  • 世界のTNF阻害剤 市場集中度
    • 世界のTNF阻害剤 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: TNF阻害剤の収益 2021
  • TNF阻害剤の主要企業の本社および事業エリア
  • 主要企業 TNF阻害剤の製品ソリューションおよびサービス
  • 市場参入時期: TNF阻害剤 市場
  • M&A, 拡張計画

第4章 TNF阻害剤 内訳データ:タイプ別

  • 世界のTNF阻害剤の市場規模実績:タイプ別 (2017-2022)
  • 世界のTNF阻害剤の市場規模予測:タイプ別 (2023-2028)

第5章 TNF阻害剤 内訳データ:アプリケーション別

  • 世界のTNF阻害剤の市場規模実績:アプリケーション別 (2017-2022)
  • 世界のTNF阻害剤の市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のTNF阻害剤 市場規模 (2017-2028)
  • 北米のTNF阻害剤 市場規模:タイプ別
    • 北米のTNF阻害剤 市場規模:タイプ別 (2017-2022)
    • 北米のTNF阻害剤 市場規模:タイプ別 (2023-2028)
    • 北米のTNF阻害剤の市場シェア:タイプ別 (2017-2028)
  • 北米のTNF阻害剤 市場規模:アプリケーション別
    • 北米のTNF阻害剤 市場規模:アプリケーション別 (2017-2022)
    • 北米のTNF阻害剤 市場規模:アプリケーション別 (2023-2028)
    • 北米のTNF阻害剤の市場シェア:アプリケーション別 (2017-2028)
  • 北米のTNF阻害剤 市場規模:国別
    • 北米のTNF阻害剤 市場規模:国別 (2017-2022)
    • 北米のTNF阻害剤 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のTNF阻害剤 市場規模 (2017-2028)
  • 欧州のTNF阻害剤 市場規模:タイプ別
    • 欧州のTNF阻害剤 市場規模:タイプ別 (2017-2022)
    • 欧州のTNF阻害剤 市場規模:タイプ別 (2023-2028)
    • 欧州のTNF阻害剤の市場シェア:タイプ別 (2017-2028)
  • 欧州のTNF阻害剤 市場規模:アプリケーション別
    • 欧州のTNF阻害剤 市場規模:アプリケーション別 (2017-2022)
    • 欧州のTNF阻害剤 市場規模:アプリケーション別 (2023-2028)
    • 欧州のTNF阻害剤の市場シェア:アプリケーション別 (2017-2028)
  • 欧州のTNF阻害剤 市場規模:国別
    • 欧州のTNF阻害剤 市場規模:国別 (2017-2022)
    • 欧州のTNF阻害剤 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 TNF阻害剤 市場規模 (2017-2028)
  • アジア太平洋地域 TNF阻害剤 市場規模:タイプ別
    • アジア太平洋地域 TNF阻害剤 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 TNF阻害剤 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 TNF阻害剤の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 TNF阻害剤 市場規模:アプリケーション別
    • アジア太平洋地域 TNF阻害剤 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 TNF阻害剤 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 TNF阻害剤の市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 TNF阻害剤 市場規模:地域別
    • アジア太平洋地域 TNF阻害剤 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 TNF阻害剤 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのTNF阻害剤 市場規模 (2017-2028)
  • ラテンアメリカのTNF阻害剤 市場規模:タイプ別
    • ラテンアメリカのTNF阻害剤 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカのTNF阻害剤 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカのTNF阻害剤の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカのTNF阻害剤 市場規模:アプリケーション別
    • ラテンアメリカのTNF阻害剤 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカのTNF阻害剤 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカのTNF阻害剤の市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカのTNF阻害剤 市場規模:国別
    • ラテンアメリカのTNF阻害剤 市場規模:国別 (2017-2022)
    • ラテンアメリカのTNF阻害剤 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのTNF阻害剤 市場規模 (2017-2028)
  • 中東・アフリカのTNF阻害剤 市場規模:タイプ別
    • 中東・アフリカのTNF阻害剤 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカのTNF阻害剤 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカのTNF阻害剤の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカのTNF阻害剤 市場規模:アプリケーション別
    • 中東・アフリカのTNF阻害剤 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカのTNF阻害剤 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカのTNF阻害剤の市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカのTNF阻害剤 市場規模:国別
    • 中東・アフリカのTNF阻害剤 市場規模:国別 (2017-2022)
    • 中東・アフリカのTNF阻害剤 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Pfizer
  • Novartis
  • Boehringer Ingelheim
  • Amgen
  • BioPharma
  • Mochida Pharmaceutical
  • Hanall

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global TNF Inhibitors Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Monotherapy
  • Table 3. Key Players of Combination Therapy
  • Table 4. Global TNF Inhibitors Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global TNF Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global TNF Inhibitors Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global TNF Inhibitors Market Share by Region (2017-2022)
  • Table 8. Global TNF Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global TNF Inhibitors Market Share by Region (2023-2028)
  • Table 10. TNF Inhibitors Market Trends
  • Table 11. TNF Inhibitors Market Drivers
  • Table 12. TNF Inhibitors Market Challenges
  • Table 13. TNF Inhibitors Market Restraints
  • Table 14. Global TNF Inhibitors Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global TNF Inhibitors Revenue Share by Players (2017-2022)
  • Table 16. Global Top TNF Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TNF Inhibitors as of 2021)
  • Table 17. Ranking of Global Top TNF Inhibitors Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by TNF Inhibitors Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players TNF Inhibitors Product Solution and Service
  • Table 21. Date of Enter into TNF Inhibitors Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global TNF Inhibitors Revenue Market Share by Type (2017-2022)
  • Table 25. Global TNF Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global TNF Inhibitors Revenue Market Share by Type (2023-2028)
  • Table 27. Global TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global TNF Inhibitors Revenue Share by Application (2017-2022)
  • Table 29. Global TNF Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global TNF Inhibitors Revenue Share by Application (2023-2028)
  • Table 31. North America TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America TNF Inhibitors Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America TNF Inhibitors Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America TNF Inhibitors Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America TNF Inhibitors Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe TNF Inhibitors Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe TNF Inhibitors Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe TNF Inhibitors Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe TNF Inhibitors Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific TNF Inhibitors Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific TNF Inhibitors Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific TNF Inhibitors Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific TNF Inhibitors Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America TNF Inhibitors Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America TNF Inhibitors Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America TNF Inhibitors Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America TNF Inhibitors Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa TNF Inhibitors Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa TNF Inhibitors Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa TNF Inhibitors Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa TNF Inhibitors Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa TNF Inhibitors Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa TNF Inhibitors Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Pfizer Company Details
  • Table 62. Pfizer Business Overview
  • Table 63. Pfizer TNF Inhibitors Product
  • Table 64. Pfizer Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 65. Pfizer Recent Developments
  • Table 66. Novartis Company Details
  • Table 67. Novartis Business Overview
  • Table 68. Novartis TNF Inhibitors Product
  • Table 69. Novartis Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 70. Novartis Recent Developments
  • Table 71. Boehringer Ingelheim Company Details
  • Table 72. Boehringer Ingelheim Business Overview
  • Table 73. Boehringer Ingelheim TNF Inhibitors Product
  • Table 74. Boehringer Ingelheim Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 75. Boehringer Ingelheim Recent Developments
  • Table 76. Amgen Company Details
  • Table 77. Amgen Business Overview
  • Table 78. Amgen TNF Inhibitors Product
  • Table 79. Amgen Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 80. Amgen Recent Developments
  • Table 81. BioPharma Company Details
  • Table 82. BioPharma Business Overview
  • Table 83. BioPharma TNF Inhibitors Product
  • Table 84. BioPharma Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 85. BioPharma Recent Developments
  • Table 86. Mochida Pharmaceutical Company Details
  • Table 87. Mochida Pharmaceutical Business Overview
  • Table 88. Mochida Pharmaceutical TNF Inhibitors Product
  • Table 89. Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 90. Mochida Pharmaceutical Recent Developments
  • Table 91. Hanall Company Details
  • Table 92. Hanall Business Overview
  • Table 93. Hanall TNF Inhibitors Product
  • Table 94. Hanall Revenue in TNF Inhibitors Business (2017-2022) & (US$ Million)
  • Table 95. Hanall Recent Developments
  • Table 96. Research Programs/Design for This Report
  • Table 97. Key Data Information from Secondary Sources
  • Table 98. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global TNF Inhibitors Market Share by Type: 2021 VS 2028
  • Figure 2. Monotherapy Features
  • Figure 3. Combination Therapy Features
  • Figure 4. Global TNF Inhibitors Market Share by Application: 2021 VS 2028
  • Figure 5. Skin Disease Case Studies
  • Figure 6. Ankylosing Spondylitis Case Studies
  • Figure 7. Gastrointestinal Disease Case Studies
  • Figure 8. Rheumatoid Arthritis Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. TNF Inhibitors Report Years Considered
  • Figure 11. Global TNF Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global TNF Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global TNF Inhibitors Market Share by Region: 2021 VS 2028
  • Figure 14. Global TNF Inhibitors Market Share by Players in 2021
  • Figure 15. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TNF Inhibitors as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by TNF Inhibitors Revenue in 2021
  • Figure 17. North America TNF Inhibitors Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America TNF Inhibitors Market Size Market Share by Type (2017-2028)
  • Figure 19. North America TNF Inhibitors Market Size Market Share by Application (2017-2028)
  • Figure 20. North America TNF Inhibitors Market Size Share by Country (2017-2028)
  • Figure 21. United States TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe TNF Inhibitors Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe TNF Inhibitors Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe TNF Inhibitors Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe TNF Inhibitors Market Size Share by Country (2017-2028)
  • Figure 27. Germany TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific TNF Inhibitors Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific TNF Inhibitors Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific TNF Inhibitors Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific TNF Inhibitors Market Size Share by Region (2017-2028)
  • Figure 37. China TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 43. Latin America TNF Inhibitors Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America TNF Inhibitors Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America TNF Inhibitors Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America TNF Inhibitors Market Size Share by Country (2017-2028)
  • Figure 47. Mexico TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa TNF Inhibitors Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa TNF Inhibitors Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa TNF Inhibitors Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa TNF Inhibitors Market Size Share by Country (2017-2028)
  • Figure 53. Turkey TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE TNF Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Pfizer Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 57. Novartis Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 58. Boehringer Ingelheim Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 59. Amgen Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 60. BioPharma Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 61. Mochida Pharmaceutical Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 62. Hanall Revenue Growth Rate in TNF Inhibitors Business (2017-2022)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed
目次

This research report focuses on the TNF Inhibitors Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global TNF Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Monotherapy
    • 1.2.3 Combination Therapy
  • 1.3 Market by Application
    • 1.3.1 Global TNF Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Skin Disease
    • 1.3.3 Ankylosing Spondylitis
    • 1.3.4 Gastrointestinal Disease
    • 1.3.5 Rheumatoid Arthritis
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global TNF Inhibitors Market Perspective (2017-2028)
  • 2.2 TNF Inhibitors Growth Trends by Region
    • 2.2.1 TNF Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 TNF Inhibitors Historic Market Size by Region (2017-2022)
    • 2.2.3 TNF Inhibitors Forecasted Market Size by Region (2023-2028)
  • 2.3 TNF Inhibitors Market Dynamics
    • 2.3.1 TNF Inhibitors Industry Trends
    • 2.3.2 TNF Inhibitors Market Drivers
    • 2.3.3 TNF Inhibitors Market Challenges
    • 2.3.4 TNF Inhibitors Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top TNF Inhibitors Players by Revenue
    • 3.1.1 Global Top TNF Inhibitors Players by Revenue (2017-2022)
    • 3.1.2 Global TNF Inhibitors Revenue Market Share by Players (2017-2022)
  • 3.2 Global TNF Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by TNF Inhibitors Revenue
  • 3.4 Global TNF Inhibitors Market Concentration Ratio
    • 3.4.1 Global TNF Inhibitors Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by TNF Inhibitors Revenue in 2021
  • 3.5 TNF Inhibitors Key Players Head office and Area Served
  • 3.6 Key Players TNF Inhibitors Product Solution and Service
  • 3.7 Date of Enter into TNF Inhibitors Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 TNF Inhibitors Breakdown Data by Type

  • 4.1 Global TNF Inhibitors Historic Market Size by Type (2017-2022)
  • 4.2 Global TNF Inhibitors Forecasted Market Size by Type (2023-2028)

5 TNF Inhibitors Breakdown Data by Application

  • 5.1 Global TNF Inhibitors Historic Market Size by Application (2017-2022)
  • 5.2 Global TNF Inhibitors Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America TNF Inhibitors Market Size (2017-2028)
  • 6.2 North America TNF Inhibitors Market Size by Type
    • 6.2.1 North America TNF Inhibitors Market Size by Type (2017-2022)
    • 6.2.2 North America TNF Inhibitors Market Size by Type (2023-2028)
    • 6.2.3 North America TNF Inhibitors Market Share by Type (2017-2028)
  • 6.3 North America TNF Inhibitors Market Size by Application
    • 6.3.1 North America TNF Inhibitors Market Size by Application (2017-2022)
    • 6.3.2 North America TNF Inhibitors Market Size by Application (2023-2028)
    • 6.3.3 North America TNF Inhibitors Market Share by Application (2017-2028)
  • 6.4 North America TNF Inhibitors Market Size by Country
    • 6.4.1 North America TNF Inhibitors Market Size by Country (2017-2022)
    • 6.4.2 North America TNF Inhibitors Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe TNF Inhibitors Market Size (2017-2028)
  • 7.2 Europe TNF Inhibitors Market Size by Type
    • 7.2.1 Europe TNF Inhibitors Market Size by Type (2017-2022)
    • 7.2.2 Europe TNF Inhibitors Market Size by Type (2023-2028)
    • 7.2.3 Europe TNF Inhibitors Market Share by Type (2017-2028)
  • 7.3 Europe TNF Inhibitors Market Size by Application
    • 7.3.1 Europe TNF Inhibitors Market Size by Application (2017-2022)
    • 7.3.2 Europe TNF Inhibitors Market Size by Application (2023-2028)
    • 7.3.3 Europe TNF Inhibitors Market Share by Application (2017-2028)
  • 7.4 Europe TNF Inhibitors Market Size by Country
    • 7.4.1 Europe TNF Inhibitors Market Size by Country (2017-2022)
    • 7.4.2 Europe TNF Inhibitors Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific TNF Inhibitors Market Size (2017-2028)
  • 8.2 Asia-Pacific TNF Inhibitors Market Size by Type
    • 8.2.1 Asia-Pacific TNF Inhibitors Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific TNF Inhibitors Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific TNF Inhibitors Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific TNF Inhibitors Market Size by Application
    • 8.3.1 Asia-Pacific TNF Inhibitors Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific TNF Inhibitors Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific TNF Inhibitors Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific TNF Inhibitors Market Size by Region
    • 8.4.1 Asia-Pacific TNF Inhibitors Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific TNF Inhibitors Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America TNF Inhibitors Market Size (2017-2028)
  • 9.2 Latin America TNF Inhibitors Market Size by Type
    • 9.2.1 Latin America TNF Inhibitors Market Size by Type (2017-2022)
    • 9.2.2 Latin America TNF Inhibitors Market Size by Type (2023-2028)
    • 9.2.3 Latin America TNF Inhibitors Market Share by Type (2017-2028)
  • 9.3 Latin America TNF Inhibitors Market Size by Application
    • 9.3.1 Latin America TNF Inhibitors Market Size by Application (2017-2022)
    • 9.3.2 Latin America TNF Inhibitors Market Size by Application (2023-2028)
    • 9.3.3 Latin America TNF Inhibitors Market Share by Application (2017-2028)
  • 9.4 Latin America TNF Inhibitors Market Size by Country
    • 9.4.1 Latin America TNF Inhibitors Market Size by Country (2017-2022)
    • 9.4.2 Latin America TNF Inhibitors Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa TNF Inhibitors Market Size (2017-2028)
  • 10.2 Middle East & Africa TNF Inhibitors Market Size by Type
    • 10.2.1 Middle East & Africa TNF Inhibitors Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa TNF Inhibitors Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa TNF Inhibitors Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa TNF Inhibitors Market Size by Application
    • 10.3.1 Middle East & Africa TNF Inhibitors Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa TNF Inhibitors Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa TNF Inhibitors Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa TNF Inhibitors Market Size by Country
    • 10.4.1 Middle East & Africa TNF Inhibitors Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa TNF Inhibitors Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer TNF Inhibitors Introduction
    • 11.1.4 Pfizer Revenue in TNF Inhibitors Business (2017-2022)
    • 11.1.5 Pfizer Recent Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis TNF Inhibitors Introduction
    • 11.2.4 Novartis Revenue in TNF Inhibitors Business (2017-2022)
    • 11.2.5 Novartis Recent Developments
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim TNF Inhibitors Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in TNF Inhibitors Business (2017-2022)
    • 11.3.5 Boehringer Ingelheim Recent Developments
  • 11.4 Amgen
    • 11.4.1 Amgen Company Details
    • 11.4.2 Amgen Business Overview
    • 11.4.3 Amgen TNF Inhibitors Introduction
    • 11.4.4 Amgen Revenue in TNF Inhibitors Business (2017-2022)
    • 11.4.5 Amgen Recent Developments
  • 11.5 BioPharma
    • 11.5.1 BioPharma Company Details
    • 11.5.2 BioPharma Business Overview
    • 11.5.3 BioPharma TNF Inhibitors Introduction
    • 11.5.4 BioPharma Revenue in TNF Inhibitors Business (2017-2022)
    • 11.5.5 BioPharma Recent Developments
  • 11.6 Mochida Pharmaceutical
    • 11.6.1 Mochida Pharmaceutical Company Details
    • 11.6.2 Mochida Pharmaceutical Business Overview
    • 11.6.3 Mochida Pharmaceutical TNF Inhibitors Introduction
    • 11.6.4 Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2017-2022)
    • 11.6.5 Mochida Pharmaceutical Recent Developments
  • 11.7 Hanall
    • 11.7.1 Hanall Company Details
    • 11.7.2 Hanall Business Overview
    • 11.7.3 Hanall TNF Inhibitors Introduction
    • 11.7.4 Hanall Revenue in TNF Inhibitors Business (2017-2022)
    • 11.7.5 Hanall Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer